BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 31311113)

  • 1. RUNX3 Promotes the Tumorigenic Phenotype in KGN, a Human Granulosa Cell Tumor-Derived Cell Line.
    Chen H; Crosley P; Azad AK; Gupta N; Gokul N; Xu Z; Weinfeld M; Postovit LM; Pangas SA; Hitt MM; Fu Y
    Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31311113
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transforming growth factor alpha (TGFα) regulates granulosa cell tumor (GCT) cell proliferation and migration through activation of multiple pathways.
    Wang C; Lv X; Jiang C; Cordes CM; Fu L; Lele SM; Davis JS
    PLoS One; 2012; 7(11):e48299. PubMed ID: 23155381
    [TBL] [Abstract][Full Text] [Related]  

  • 3. YAP regulates cell proliferation, migration, and steroidogenesis in adult granulosa cell tumors.
    Fu D; Lv X; Hua G; He C; Dong J; Lele SM; Li DW; Zhai Q; Davis JS; Wang C
    Endocr Relat Cancer; 2014 Apr; 21(2):297-310. PubMed ID: 24389730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypermethylation downregulates Runx3 gene expression and its restoration suppresses gastric epithelial cell growth by inducing p27 and caspase3 in human gastric cancer.
    Chen W; Gao N; Shen Y; Cen JN
    J Gastroenterol Hepatol; 2010 Apr; 25(4):823-31. PubMed ID: 20492341
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mixtures of persistent organic pollutants increase ovarian granulosa tumor cell line migration and spheroid invasion by upregulating MMP2 expression and activity via IGF1R.
    Gogola-Mruk J; Hoffmann-Młodzianowska M; Kamińska K; Ptak A
    Toxicology; 2021 Mar; 452():152715. PubMed ID: 33571556
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endogenous c-Jun N-terminal kinase (JNK) activity marks the boundary between normal and malignant granulosa cells.
    Bildik G; Akin N; Senbabaoglu F; Esmalian Y; Sahin GN; Urman D; Karahuseyinoglu S; Ince U; Palaoglu E; Taskiran C; Arvas M; Guzel Y; Yakin K; Oktem O
    Cell Death Dis; 2018 Apr; 9(4):421. PubMed ID: 29549247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined PPARγ Activation and XIAP Inhibition as a Potential Therapeutic Strategy for Ovarian Granulosa Cell Tumors.
    Leung DTH; Nguyen T; Oliver EM; Matti J; Alexiadis M; Silke J; Jobling TW; Fuller PJ; Chu S
    Mol Cancer Ther; 2019 Feb; 18(2):364-375. PubMed ID: 30530769
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CpG methylation of the FHIT, FANCF, cyclin-D2, BRCA2 and RUNX3 genes in Granulosa cell tumors (GCTs) of ovarian origin.
    Dhillon VS; Shahid M; Husain SA
    Mol Cancer; 2004 Dec; 3():33. PubMed ID: 15574200
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 17β-estradiol inhibits spreading of metastatic cells from granulosa cell tumors through a non-genomic mechanism involving GPER1.
    François CM; Wargnier R; Petit F; Goulvent T; Rimokh R; Treilleux I; Ray-Coquard I; Zazzu V; Cohen-Tannoudji J; Guigon CJ
    Carcinogenesis; 2015 May; 36(5):564-73. PubMed ID: 25823895
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of the inhibitor of kappaB kinase (IKK) complex in granulosa cell tumors of the ovary and granulosa cell tumor-derived cell lines.
    Jamieson S; Fuller PJ
    Horm Cancer; 2013 Oct; 4(5):277-92. PubMed ID: 23674259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tyrosine Kinase Inhibitors as Potential Therapeutic Agents in the Treatment of Granulosa Cell Tumors of the Ovary.
    Jamieson S; Fuller PJ
    Int J Gynecol Cancer; 2015 Sep; 25(7):1224-31. PubMed ID: 26067856
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression status and mutational analysis of the PTEN and P13K subunit genes in ovarian granulosa cell tumors.
    Bittinger S; Alexiadis M; Fuller PJ
    Int J Gynecol Cancer; 2009 Apr; 19(3):339-42. PubMed ID: 19407556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GATA4 protects granulosa cell tumors from TRAIL-induced apoptosis.
    Kyrönlahti A; Kauppinen M; Lind E; Unkila-Kallio L; Butzow R; Klefström J; Wilson DB; Anttonen M; Heikinheimo M
    Endocr Relat Cancer; 2010 Sep; 17(3):709-17. PubMed ID: 20554787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spontaneous transformation of human granulosa cell tumours into an aggressive phenotype: a metastasis model cell line.
    Imai M; Muraki M; Takamatsu K; Saito H; Seiki M; Takahashi Y
    BMC Cancer; 2008 Nov; 8():319. PubMed ID: 18980698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transrepression of estrogen receptor beta signaling by nuclear factor-kappab in ovarian granulosa cells.
    Chu S; Nishi Y; Yanase T; Nawata H; Fuller PJ
    Mol Endocrinol; 2004 Aug; 18(8):1919-28. PubMed ID: 15155785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of E-cadherin and Runx3 in Helicobacter Pylori - Associated gastric carcinoma is achieved through regulating P21waf and P27 expression.
    Bahnassy AA; Helal TE; El-Ghazawy IM; Samaan GF; Galal El-Din MM; Abdellateif MS; Desouky E; Zekri AN
    Cancer Genet; 2018 Dec; 228-229():64-72. PubMed ID: 30553475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibitor of apoptosis proteins are potential targets for treatment of granulosa cell tumors - implications from studies in KGN.
    Bagnjuk K; Kast VJ; Tiefenbacher A; Kaseder M; Yanase T; Burges A; Kunz L; Mayr D; Mayerhofer A
    J Ovarian Res; 2019 Aug; 12(1):76. PubMed ID: 31412918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hormone-induced proliferation and differentiation of granulosa cells: a coordinated balance of the cell cycle regulators cyclin D2 and p27Kip1.
    Robker RL; Richards JS
    Mol Endocrinol; 1998 Jul; 12(7):924-40. PubMed ID: 9658398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclin D1 blocks the anti-proliferative function of RUNX3 by interfering with RUNX3-p300 interaction.
    Iwatani K; Fujimoto T; Ito T
    Biochem Biophys Res Commun; 2010 Sep; 400(3):426-31. PubMed ID: 20801098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GATA-4 regulates Bcl-2 expression in ovarian granulosa cell tumors.
    Kyrönlahti A; Rämö M; Tamminen M; Unkila-Kallio L; Butzow R; Leminen A; Nemer M; Rahman N; Huhtaniemi I; Heikinheimo M; Anttonen M
    Endocrinology; 2008 Nov; 149(11):5635-42. PubMed ID: 18653721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.